Open AccessAdjuvant Etoposide Plus Cisplatin for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumors: Is This the Preferred Option?
Author(s) -
Lawrence H. Einhorn,
Nabil Adra,
Nasser H. Hanna,
Craig R. Nichols
Publication year - 2020
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.20.00702
Subject(s) - medicine , etoposide , germ cell tumors , adjuvant , cisplatin , oncology , stage (stratigraphy) , adjuvant chemotherapy , germ cell , seminoma , chemotherapy , gynecology , cancer , paleontology , biochemistry , chemistry , breast cancer , gene , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom